Stockhub

Bellicum Pharmaceuticals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

15 August 2022

11 August 2022

3 August 2022

  • curprev 09:1609:16, 3 August 2022‎ Chris talk contribs‎ 1,109 bytes +1,109‎ Created page with "Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603,..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Bellicum_Pharmaceuticals,_Inc.’